West Pharmaceutical Services Inc. News
Tesla, Airbnb Make Morningstar List of Undervalued Stocks
The S&P 500 has rebounded 10% since Oct. 12, after dropping 25% from the beginning of the year through that date.
Looking for Leadership: Cramer's 'Mad Money' Recap (Tuesday 10/27/20)
Jim Cramer says investors should worry a little less about COVID and politics, and instead focus on business leadership that drives success -- like that of AMD CEO Lisa Su.
China Blinks, Stocks Rally: Cramer's 'Mad Money' Recap
Jim Cramer finds the key to this amazingly bullish bounce -- the breadth was stunning. It was an across-the-board romp.
7 Investment Themes You Can't Afford to Miss for 2018
The 'winning formula' for this year focuses on growth, size and foreign stocks, Jefferies says.
Phew! We Survived September: Cramer's 'Mad Money' Recap
Despite North Korea, Trump's tweets, hurricanes, and past crashes, we made it through this historically hurtful month. What's next? Cramer's got his game plan.
West Pharmaceutical (WST) Stock Stumbling, Wells Fargo Downgrades
West Pharmaceutical's (WST) stock rating was slashed to 'market perform' at Wells Fargo on Wednesday.
2 big companies and 1 small one to target in the pharma/biotech space
Catalent and West Pharmaceutical Services provide products and services to biotech and pharmaceutical firms. Intellipharmaceutics is a small-cap firm on the rise.
Strong And Under The Radar Today: West Pharmaceutical Services (WST)
Trade-Ideas LLC identified West Pharmaceutical Services (WST) as a strong and under the radar candidate
Dividend Watch: 3 Stocks Going Ex-Dividend Monday: HRZN, GHC, WST
HRZN GHC WST are going ex-dividend Monday, Monday, July 18, 2016
Don't Miss Today's Strong And Under The Radar Stock: West Pharmaceutical Services (WST)
Trade-Ideas LLC identified West Pharmaceutical Services (WST) as a strong and under the radar candidate
Breaking News
Fed Inflation Gauge Slowed Again in October, Supporting Dovish Powell
Further slowing in the Fed's preferred inflation gauge is adding heft to Chairman Jerome Powell's signals of smaller rate hikes.
Amazon Needs to Kill Alexa, Maybe Exit Echo Devices
The online retail giant had a plan to own your living room. It didn't work because AI-powered voice assistants don't work.
General Mills Tries a New Take on Lucky Charms
The new variant may be even more magically delicious.
Elon Musk's Latest Twitter Move Looks Like an Act of Desperation
Twitter is desperate for revenue. It has a $13 billion debt burden, but hasn’t showed a profit for eight of the last 10 years.